ES2320643T3 - COMPOSITIONS WITH ANISIC ACID AND GLYCERIDES. - Google Patents
COMPOSITIONS WITH ANISIC ACID AND GLYCERIDES. Download PDFInfo
- Publication number
- ES2320643T3 ES2320643T3 ES03293147T ES03293147T ES2320643T3 ES 2320643 T3 ES2320643 T3 ES 2320643T3 ES 03293147 T ES03293147 T ES 03293147T ES 03293147 T ES03293147 T ES 03293147T ES 2320643 T3 ES2320643 T3 ES 2320643T3
- Authority
- ES
- Spain
- Prior art keywords
- acid
- weight
- formulation
- salts
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 238000009472 formulation Methods 0.000 claims abstract description 72
- 239000003755 preservative agent Substances 0.000 claims abstract description 37
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 28
- 239000000194 fatty acid Substances 0.000 claims abstract description 28
- 229930195729 fatty acid Natural products 0.000 claims abstract description 28
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 20
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 150000002148 esters Chemical class 0.000 claims abstract description 15
- 230000002335 preservative effect Effects 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 13
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 11
- 125000005907 alkyl ester group Chemical group 0.000 claims description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 9
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- NJLKZOZYTRRDBO-UHFFFAOYSA-N 3-iodopropyl n-butylcarbamate Chemical compound CCCCNC(=O)OCCCI NJLKZOZYTRRDBO-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960003260 chlorhexidine Drugs 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- 229940046305 5-bromo-5-nitro-1,3-dioxane Drugs 0.000 claims description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- 239000004287 Dehydroacetic acid Substances 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- XVBRCOKDZVQYAY-UHFFFAOYSA-N bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 claims description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 claims description 2
- 229940061632 dehydroacetic acid Drugs 0.000 claims description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 claims description 2
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 claims description 2
- 229960001083 diazolidinylurea Drugs 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 229940096792 quaternium-15 Drugs 0.000 claims description 2
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229960003500 triclosan Drugs 0.000 claims description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- -1 alkyl ester polyol Chemical class 0.000 description 32
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 24
- 239000002537 cosmetic Substances 0.000 description 19
- 239000004615 ingredient Substances 0.000 description 13
- 229940120503 dihydroxyacetone Drugs 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 11
- 239000000839 emulsion Substances 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229940083542 sodium Drugs 0.000 description 9
- 230000000699 topical effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 230000037307 sensitive skin Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 206010003645 Atopy Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000036555 skin type Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- 239000012049 topical pharmaceutical composition Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002535 acidifier Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000001998 anti-microbiological effect Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229960002887 deanol Drugs 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 229920001296 polysiloxane Chemical class 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- XOAIXMQPJQVGRV-UHFFFAOYSA-N 1-hexadecanoylpyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N1CCCC1C(O)=O XOAIXMQPJQVGRV-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FPVJYHHGNGJAPC-UHFFFAOYSA-N 2-[3-(decanoylamino)propyl-dimethylazaniumyl]acetate Chemical compound CCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O FPVJYHHGNGJAPC-UHFFFAOYSA-N 0.000 description 1
- UIJMHOVIUFGSNF-UHFFFAOYSA-N 2-[dimethyl-[3-(undec-10-enoylamino)propyl]azaniumyl]acetate Chemical compound [O-]C(=O)C[N+](C)(C)CCCNC(=O)CCCCCCCCC=C UIJMHOVIUFGSNF-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- LCVHZNSIAYNAGX-UHFFFAOYSA-N 2-ethylhexyl 3,5,5-trimethylhexanoate Chemical compound CCCCC(CC)COC(=O)CC(C)CC(C)(C)C LCVHZNSIAYNAGX-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004251 Ammonium lactate Substances 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- YCSMVPSDJIOXGN-UHFFFAOYSA-N CCCCCCCCCCCC[Na] Chemical compound CCCCCCCCCCCC[Na] YCSMVPSDJIOXGN-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 240000003409 Gentiana lutea Species 0.000 description 1
- 235000002873 Gentiana lutea Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical compound COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000016856 Palma redonda Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- MWAZVPWTTWPXJF-UHFFFAOYSA-N acetic acid;urea Chemical compound CC(O)=O.NC(N)=O MWAZVPWTTWPXJF-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical class [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940059265 ammonium lactate Drugs 0.000 description 1
- 235000019286 ammonium lactate Nutrition 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 1
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940073742 capramidopropyl betaine Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960002788 cetrimonium chloride Drugs 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- QMIFIFIYYPUVNU-ACMTZBLWSA-L copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-imidazol-1-id-4-ylpropanoyl]amino]hexanoate Chemical compound [Cu+2].NCCCC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)CN)CC1=C[N-]C=N1 QMIFIFIYYPUVNU-ACMTZBLWSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical compound [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 description 1
- VNDITZXAIQXZJI-UHFFFAOYSA-L disodium 1-dodecoxydodecane 2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O.CCCCCCCCCCCCOCCCCCCCCCCCC VNDITZXAIQXZJI-UHFFFAOYSA-L 0.000 description 1
- XQYSTRMEVGHJAW-UHFFFAOYSA-L disodium;1-tridecoxytridecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCCOCCCCCCCCCCCCC XQYSTRMEVGHJAW-UHFFFAOYSA-L 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- QLVARBCGUNCRTA-LOYHVIPDSA-N ditetradecyl (2r,3r)-2,3-dihydroxybutanedioate Chemical compound CCCCCCCCCCCCCCOC(=O)[C@H](O)[C@@H](O)C(=O)OCCCCCCCCCCCCCC QLVARBCGUNCRTA-LOYHVIPDSA-N 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- BXOUVIIITJXIKB-UHFFFAOYSA-N ethene;styrene Chemical compound C=C.C=CC1=CC=CC=C1 BXOUVIIITJXIKB-UHFFFAOYSA-N 0.000 description 1
- LRMHFDNWKCSEQU-UHFFFAOYSA-N ethoxyethane;phenol Chemical compound CCOCC.OC1=CC=CC=C1 LRMHFDNWKCSEQU-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940100549 ethylhexyl isononanoate Drugs 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940100556 laureth-23 Drugs 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 1
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940068988 potassium aspartate Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000002437 shaving preparation Substances 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-M sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- PNGBYKXZVCIZRN-UHFFFAOYSA-M sodium;hexadecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCCCCCS([O-])(=O)=O PNGBYKXZVCIZRN-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Detergent Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Description
Composiciones con ácido anísico y glicéridos.Compositions with anisic acid and glycerides
Esta invención se refiere a formulaciones que contienen una combinación de ácido anísico, o una de sus sales o uno de sus ésteres, y un monoglicérido de ácido graso C_{6-14} y al uso de tales combinaciones como sistema conservante.This invention relates to formulations that they contain a combination of anisic acid, or one of its salts or one of its esters, and a fatty acid monoglyceride C_ {6-14} and the use of such combinations as preservative system
Los conservantes son ingredientes que tienen actividad microbiana que se usan frecuentemente en productos cosméticos para el cuidado de la piel. Los conservantes son usados como protectores de estos productos frente a la degradación o putrefacción, de manera que estos productos quedan protegidos de la descomposición y el deterioro y permanecen estables durante prolongados períodos de tiempo, en particular durante la vida entera hasta caducidad de los productos.Preservatives are ingredients that have microbial activity that are frequently used in products Cosmetics for skin care. Preservatives are used as protectors of these products against degradation or rot, so that these products are protected from decomposition and deterioration and remain stable for prolonged periods of time, particularly throughout life until expiration of the products.
Una desventaja de usar tales agentes es que pueden causar efectos adversos tales como respuestas alérgicas e irritación. Son ejemplos de conservantes que son menos tolerados, en especial a una concentración incrementada, los parabenos y el fenoxietanol.A disadvantage of using such agents is that they can cause adverse effects such as allergic responses and irritation. They are examples of preservatives that are less tolerated, in special at an increased concentration, the parabens and the phenoxyethanol
Este es el caso especialmente cuando se aplican formulaciones cosméticas que contienen conservantes a tipos de piel sensibles tales como tipos de piel atópicos. Esta es la razón de que, hasta el momento, las formulaciones cosméticas que se pueden aplicar a tipos de piel sensibles (tales como, por ejemplo, piel atópica, piel de niño de pecho, piel alterada por el sol, piel alergénica) contienen menos conservantes y, por ello, son más propensas a ser afectadas y degradadas por microorganismos, siendo además fuente de contaminación microbiana.This is the case especially when applied cosmetic formulations containing preservatives to skin types sensitive such as atopic skin types. This is the reason for that, so far, the cosmetic formulations that can be apply to sensitive skin types (such as, for example, skin atopic, chest child skin, sun-altered skin, skin allergenic) contain less preservatives and, therefore, are more prone to be affected and degraded by microorganisms, being also source of microbial contamination.
Los agentes conservantes preferentemente deben estar presentes en una concentración tan baja como sea posible. Evidentemente, un factor limitativo es que las formulaciones necesitan ser protegidas adecuadamente. Por tanto, se podría estar inclinado a reducir la cantidad de conservante en formulaciones cosméticas, en particular en aquellas formulaciones que se usan o se pueden usar en tipos de piel sensibles. Al hacerlo, se podría esperar que los efectos secundarios se redujeran o incluso desaparecieran completamente. Sin embargo, ello podría dar por resultado que la concentración del conservante fuera demasiado baja para ser eficaz, resultando un riesgo inaceptable de que la formulación fuera afectada por microorganismos.Preservative agents should preferably be present in a concentration as low as possible. Obviously, a limiting factor is that the formulations They need to be adequately protected. Therefore, it could be inclined to reduce the amount of preservative in formulations cosmetics, particularly in those formulations that are used or They can be used on sensitive skin types. In doing so, you could expect side effects to be reduced or even disappear completely. However, this could lead to result that the concentration of the preservative was too low to be effective, resulting in an unacceptable risk that the formulation was affected by microorganisms.
Por tanto, sería deseable proporcionar formulaciones para el cuidado de la piel o de uso cosmético que estuvieran suficientemente protegidas frente a la contaminación microbiológica y no fueran susceptibles de degradación y deterioro microbiológicos. Adicionalmente sería deseable proporcionar tales formulaciones exentas de efectos adversos que típicamente están asociados con el uso de agentes conservantes tradicionales, en particular, en el caso de la aplicación de formulaciones cosméticas a tipos de piel sensibles.Therefore, it would be desirable to provide skin care or cosmetic use formulations that were sufficiently protected against contamination microbiological and were not susceptible to degradation and deterioration microbiological Additionally it would be desirable to provide such formulations free of adverse effects that are typically associated with the use of traditional preservative agents, in in particular, in the case of the application of cosmetic formulations to sensitive skin types.
Otra razón para tener cantidades bajas de agentes conservantes en las formulaciones es que éstos pueden reaccionar con ciertos componentes presentes en las formulaciones, en particular con ciertos ingredientes activos sensibles. Por tanto, ciertas categorías de formulación no son fáciles de conservar. Una clase de producto particular es la de productos de autobronceado, en particular, los basados en dihidroxiacetona (DHA), que es un componente que se descompone fácilmente por causas físicas así como químicas. La presencia de ciertos ingredientes en formulaciones que contienen DHA promueve la degradación de este ingrediente activo y compromete la estabilidad de formulaciones de autobronceado basadas en DHA.Another reason to have low amounts of preservative agents in the formulations is that these can react with certain components present in the formulations, in particular with certain sensitive active ingredients. By therefore, certain formulation categories are not easy to keep. A particular product class is that of products of self-tanning, in particular, those based on dihydroxyacetone (DHA), which is a component that breaks down easily due to causes Physical as well as chemical. The presence of certain ingredients in formulations containing DHA promotes the degradation of this active ingredient and compromises the stability of formulations of self-tanning based on DHA.
Por ello, es una necesidad particular tener sistemas conservantes que sean eficaces en formulaciones de autobronceado basadas en DHA.Therefore, it is a particular need to have preservative systems that are effective in formulations of self-tanning based on DHA.
El documento FR-2 834 459 describe el uso de una combinación de ácido anísico, una sal o un éster alquílico poliol y un tensioactivo catiónico como agente antimicrobiano en formulaciones cosméticas, en particular en composiciones para el tratamiento del cabello tales como champúes.Document FR-2 834 459 describes the use of a combination of anisic acid, a salt or a alkyl ester polyol and a cationic surfactant as agent antimicrobial in cosmetic formulations, particularly in hair treatment compositions such as shampoos
En el documento EP 0 884 045 A1 se proporciona una composición que es útil para dar color a la piel por autobronceado y que tiene una estabilidad mejorada. Estas composiciones comprenden de aproximadamente 0,5% a aproximadamente 20,0% en peso de un agente que colorea la piel por autobronceado tal como dihidroxiacetona, de aproximadamente 2,0% a aproximadamente 40% en peso de un polietoxiglicol, preferiblemente etoxidiglicol, y de aproximadamente 0,1% a aproximadamente 15,0% en peso de un poliol que comprende un compuesto polhidroxílico que tiene como mínimo tres grupos hidroxilo y como mínimo tres átomos de carbono, que preferiblemente es D-sorbitol. En una realización alternativa, además de los tres ingredientes mencionados, la composición puede comprender también de aproximadamente 0,1% a aproximadamente 8,0% en peso de un compuesto dihidroxílico soluble en agua que como mínimo tiene dos y hasta ocho átomos de carbono, preferiblemente etilenglicol, y un agente acidificante en una cantidad suficiente para mantener el pH de la composición total en el intervalo de aproximadamente 3,5 a aproximadamente 4,5. Los agentes acidificantes adecuados se pueden seleccionar entre el grupo constituido esencialmente por los ácidos acético, adípico, anísico, benzoico, bórico, carbónico, cinámico, cítrico, difosfónico, fórmico, fumárico, gálico, glutárico, glicólico, láctico, maleico, málico, malónico, oxálico, ftálico, propiónico, pirogálico, pirúvico, salicílico, succínico, tartárico y vainílico. Con las composiciones antes mencionadas se puede retrasar el progreso de la degradación de compuestos tales como dihidroxiacetona.EP 0 884 045 A1 provides a composition that is useful for giving skin color by self tanning and that has improved stability. These compositions comprise from about 0.5% to about 20.0% by weight of an agent that colors the skin by self tanning such as dihydroxyacetone, from about 2.0% to about 40% by weight of a polyethoxyglycol, preferably ethoxyglycol, and from about 0.1% to about 15.0% by weight of a polyol comprising a polyhydroxy compound having as at least three hydroxyl groups and at least three carbon atoms, which is preferably D-sorbitol. In a alternative embodiment, in addition to the three ingredients mentioned, the composition may also comprise of about 0.1% to about 8.0% by weight of a compound water soluble dihydroxy which has at least two and up to eight carbon atoms, preferably ethylene glycol, and an agent acidifier in an amount sufficient to maintain the pH of the total composition in the range of about 3.5 to approximately 4.5. Suitable acidifying agents can be select from the group consisting essentially of acids acetic, adipic, anisic, benzoic, boric, carbonic, cinnamic, citric, diphosphonic, formic, fumaric, gallic, glutaric, glycolic, lactic, maleic, malic, malonic, oxalic, phthalic, propionic, pyrogallic, pyruvic, salicylic, succinic, tartaric and vanilla. With the aforementioned compositions you can delay the progress of the degradation of compounds such as dihydroxyacetone
En el documento JP 48 019940 B se describe una composición cosmética que comprende una cantidad adecuada de monoglicérido del ácido caprílico o monoglicérido del ácido caprico, preferiblemente en una cantidad no superior a 20% en peso. Los monoglicéridos mencionados tienen una acción antiséptica y pueden prevenir el deterioro de composiciones cosméticas tales como cremas, emulsiones, cosméticos para maquillar, cosméticos para el cabello, detergentes, cosméticos medicinales, etc.JP 48 019940 B describes a cosmetic composition comprising an adequate amount of caprylic acid monoglyceride or capric acid monoglyceride, preferably in an amount not exceeding 20% by weight. The mentioned monoglycerides have an antiseptic action and can prevent the deterioration of cosmetic compositions such as creams, emulsions, makeup cosmetics, cosmetics for hair, detergents, medicinal cosmetics, etc.
Por el documento U.S. 4.645.662 se conoce que se puede derivar una composición oral tal como una pasta dentífrica para prevenir y remediar la hipersensibilidad de la dentina, que comprende un aluminio y un compuesto carboxilato en estado solubilizado y que tiene un pH de más de 5. El compuesto carboxilato es un monocarboxilato seleccionado entre lactato, gluconato y glicolato, y la relación de mono del compuesto carboxilato a aluminio es de 0,7 a 4. Esta composición puede comprender además de 10 a 17% en peso de un humectante tal como sorbitol, de 0 a 7% en peso de un tensioactivo tal como un monoglicérido de ácido graso de coco hidrogenado y de 0 a 1% en peso de un edulcorante, por ejemplo sacarina, o un conservante tal como un monoglicérido de un ácido graso inferior.For the U.S. document 4,645,662 is known to be can derive an oral composition such as a toothpaste to prevent and remedy dentine hypersensitivity, which it comprises an aluminum and a carboxylate compound in the state solubilized and having a pH of more than 5. The carboxylate compound it is a monocarboxylate selected from lactate, gluconate and glycolate, and the mono ratio of the carboxylate compound to Aluminum is 0.7 to 4. This composition may comprise in addition to 10 to 17% by weight of a humectant such as sorbitol, 0 to 7% in weight of a surfactant such as a fatty acid monoglyceride of hydrogenated coconut and 0 to 1% by weight of a sweetener, for example saccharin, or a preservative such as a monoglyceride of an acid lower fat.
De acuerdo con el documento GB 297.074 A, los productos alimenticios y los preparados técnicos y farmacéuticos se pueden conservar con el uso de un fenoléter o derivado de fenoléter no tóxico fenoles libres.According to GB 297.074 A, the food products and technical and pharmaceutical preparations are can be preserved with the use of a phenol ether or phenol derivative Non toxic free phenols.
Las formulaciones de la presente invención se pretende que satisfagan estas necesidades. El uso de una combinación de ácido anísico y ciertos monoglicéridos de ácido graso permite reducir la cantidad de agentes conservantes o eliminar completamente tales conservantes tradicionales en formulaciones cosméticas y para el cuidado de la piel y en particular permite proporcionar sistemas conservantes en formulaciones autobronceadoras basadas en DHA.The formulations of the present invention are It is intended to meet these needs. The use of a combination of anisic acid and certain fatty acid monoglycerides allows reduce the amount of preservatives or eliminate completely such traditional preservatives in formulations cosmetics and for skin care and in particular allows provide preservative systems in self-tanning formulations DHA based.
Actualmente no se usan el ácido anísico ni el caprilato de glicerilo como conservantes. El ácido anísico se usa como material fragante y el caprilato de glicerilo se usa como humectante y emoliente.Currently, anisic acid and glyceryl caprylate as preservatives. Anisic acid is used. as a fragrant material and glyceryl caprylate is used as moisturizer and emollient.
La presente invención concierne a formulaciones para uso sobre la piel, que comprenden una combinación de ácido anísico o una de sus sales, o uno de sus ésteres de alquilo C_{1-4}, y un monoglicérido de ácido graso C_{6-14}.The present invention concerns formulations for use on the skin, which comprise a combination of acid anisic or one of its salts, or one of its alkyl esters C 1-4, and a fatty acid monoglyceride C_ {6-14}.
En un aspecto alternativo, la invención concierne al uso de una combinación de ácido anísico o una de sus sales, o uno de sus ésteres de alquilo C_{1-4}, y un monoglicérido de ácido graso C_{6-14} como sistema conservante. Esta invención concierne también al uso de una combinación de ácido anísico o una de sus sales, o uno de sus ésteres de alquilo C_{1-4}, y un monoglicérido de ácido graso C_{6-14} para rebajar la cantidad de agentes conservantes en formulaciones para uso tópico.In an alternative aspect, the invention concerns the use of a combination of anisic acid or one of its salts, or one of its C 1-4 alkyl esters, and a C 6-14 fatty acid monoglyceride as preservative system This invention also concerns the use of a combination of anisic acid or one of its salts, or one of its C 1-4 alkyl esters, and a monoglyceride of C 6-14 fatty acid to reduce the amount of preservative agents in formulations for topical use.
La presente invención concierne a formulaciones para uso tópico que comprenden:The present invention concerns formulations for topical use comprising:
- (a)(to)
- de 0,01 a 2% de ácido anísico, o una de sus sales, o uno de sus ésteres, yfrom 0.01 to 2% anisic acid, or one of its salts, or one of its esters, and
- (b)(b)
- de 0,1 a 10% de monoglicérido de ácido graso C_{6-14}.from 0.1 to 10% fatty acid monoglyceride C_ {6-14}.
Son preferidas formulaciones de acuerdo con la presente invención que tienen un bajo contenido de agentes conservantes.Formulations according to the present invention that have a low agent content preservatives
En un aspecto preferente, esta invención concierne a formulaciones autobronceadoras que contienen dihidroxiacetona como ingrediente activo autobronceador y una combinación de ácido anísico o una de sus sales, o uno de sus ésteres de alquilo C_{1-4}, y un monoglicérido de ácido graso C_{6-14}.In a preferred aspect, this invention concerns self-tanning formulations that contain dihydroxyacetone as an active self tanning ingredient and a combination of anisic acid or one of its salts, or one of its C 1-4 alkyl esters, and a monoglyceride of C 6-14 fatty acid.
En otro aspecto, se proporciona una formulación definida aquí en la que el conservante está presente en una cantidad que es inferior a la eficaz.In another aspect, a formulation is provided defined here in which the preservative is present in a amount that is less than effective.
Las formulaciones de esta invención contienen ácido anísico o ácido o-metoxibenzoico, m-metoxibenzoico o p-metoxibenzoico, o una de sus sales, o uno de sus ésteres de alquilo C_{1-4}. Las sales comprenden sales no tóxicas tales como sales de metales alcalinos, en particular las sales sódicas y potásicas, las sales de metales alcalinotérreos, en particular las sales magnésicas y cálcicas, y las sales amónicas o derivadas de amonio tales como las sales de alquilamonio, trietanolamina y similares. Los ésteres de alquilo C_{1-4} comprenden los ésteres de metilo, etilo, n-propilo, i-propilo, n-butilo, i-butilo y t-butilo.The formulations of this invention contain anisic acid or o-methoxybenzoic acid, m-methoxybenzoic or p-methoxybenzoic, or one of its salts, or one of its alkyl esters C_ {1-4}. The salts comprise non-toxic salts such as alkali metal salts, in particular salts sodium and potassium, alkaline earth metal salts, in particular magnesium and calcium salts, and ammonium salts or ammonium derivatives such as alkylammonium salts, triethanolamine and the like. Alkyl esters C 1-4 comprise methyl, ethyl esters, n-propyl, i-propyl, n-butyl, i-butyl and t-butyl
Es preferido el ácido p-anísico, o una de sus sales o uno de sus ésteres de alquilo C_{1-4}.P-anisic acid is preferred, or one of its salts or one of its alkyl esters C_ {1-4}.
\newpage\ newpage
El ácido graso C_{6-14} de los monoglicéridos es un ácido graso sustituido o no sustituido, saturado o insaturado, de cadena lineal o ramificada, que tiene una longitud de cadena de aproximadamente 6 a aproximadamente 14 átomos de carbono. Son ejemplos ácido caproico, ácido caprílico, ácido caprico, ácido láurico y ácido mirístico. Son preferidos los monoglicéridos de ácido graso C_{6-10}, en particular, los monoglicéridos de ácido graso C_{8}.The C 6-14 fatty acid of monoglycerides is a substituted or unsubstituted fatty acid, saturated or unsaturated, straight or branched chain, which has a chain length from about 6 to about 14 atoms carbon Examples are caproic acid, caprylic acid, acid Capric, lauric acid and myristic acid. Preferred are C 6-10 fatty acid monoglycerides, in in particular, the C8 fatty acid monoglycerides.
Un monoglicérido de ácido graso C_{6-14} particularmente preferido es el caprilato de glicerilo.A fatty acid monoglyceride Particularly preferred C 6-14 is caprylate of glyceryl.
El ácido anísico puede estar presente a concentraciones de 0,01 a 2% en peso, preferiblemente de 0,1 a 1% en peso, por ejemplo, a una concentración de aproximadamente 0,2% en peso, calculada en relación al ácido puro. En el caso de sales o ésteres, se han de recalcular estos valores como corresponda.Anisic acid may be present at concentrations of 0.01 to 2% by weight, preferably 0.1 to 1% by weight, for example, at a concentration of about 0.2% in weight, calculated in relation to pure acid. In the case of salts or esters, these values have to be recalculated accordingly.
Los monoglicéridos pueden estar presentes a concentraciones de 0,1 a 10% en peso, preferiblemente de 0,3 a 5% en peso, más preferiblemente de 0,5 a 3% en peso, por ejemplo, a una concentración de aproximadamente 1% en peso.Monoglycerides may be present at concentrations of 0.1 to 10% by weight, preferably 0.3 to 5% by weight, more preferably 0.5 to 3% by weight, for example, at a concentration of approximately 1% by weight.
En un aspecto particular, la presente invención concierne a formulaciones para uso tópico que comprenden:In a particular aspect, the present invention concerns formulations for topical use comprising:
- (a)(to)
- de 0,01 a 2% en peso de ácido p-anísico, o una de sus sales o uno de sus ésteres,from 0.01 to 2% by weight of p-anisic acid, or one of its salts or one of its esters,
- (b)(b)
- de 0,1 a 10% en peso de caprilato de glicerilo.from 0.1 to 10% by weight of glyceryl caprylate.
En otro aspecto particular más, la presente invención concierne a formulaciones para usó tópico que comprendenIn another particular aspect, the present invention concerns formulations for topical use that understand
- (a)(to)
- de 0,01 a 2% en peso de ácido p-anísico, o una de sus sales o uno de sus ésteres, yfrom 0.01 to 2% by weight of p-anisic acid, or one of its salts or one of its esters, and
- (b)(b)
- de 0,1 a 10% en peso de caprilato de glicerilo,from 0.1 to 10% by weight of glyceryl caprylate,
- (c)(C)
- menos de 1% en peso de un agente conservante, en particular menos de 0,5% en peso de agente conservante.less than 1% by weight of an agent preservative, in particular less than 0.5% by weight of agent preservative
Son realizaciones específicas formulaciones para uso tópico que comprendenSpecific embodiments are formulations for topical use that they understand
- (a)(to)
- de 0,01 a 2% en peso de ácido p-anísico, o una de sus sales o uno de sus ésteres, yfrom 0.01 to 2% by weight of p-anisic acid, or one of its salts or one of its esters, and
- (b)(b)
- de 0,1 a 10% en peso de caprilato de glicerilo,from 0.1 to 10% by weight of glyceryl caprylate,
- (c)(C)
- menos de 0,4% en peso de parabenos, o menos de 100 ppm de yodopropinilbutilcarbamato, o menos de 0,5% de fenoxietanol.less than 0.4% by weight of parabens, or less than 100 ppm of iodopropylbutylcarbamate, or less than 0.5% of phenoxyethanol
Los conservantes tradicionales comprenden fenoxietanol, alquilparabenos y sus sales, en particular sus sales de metales alcalinos, tales como las sales sódicas (por ejemplo, alquil C_{1-6} parabenos tales como parabenos de metilo, etilo, propilo, butilo y parabenos similares), clorohexidina y similares, yodopropinilbutilcarbamato, también denominado butil-3-yodo-2-propinil-carbamato. Otros conservantes son formaldehído o liberadores de formaldehído, por ejemplo, DMDM hidantoína, alcohol bencílico, metilcloroisotiazolinona, metilisotiazolinona, benzoato sódico, clorohexidina, digluconato, metildibromo glutaronitrilo, 5-bromo-5-nitro-1,3-dioxano, ácido benzoico, ácido dehidroacético, diazolidinilurea, poliaminopropilbiguanida, sorbato potásico, quaternium-15, ácido sórbico, triclosano y similares. Tal como se usa aquí, el término "conservante" comprende también mezclas de conservantes.Traditional preservatives comprise phenoxyethanol, alkylparabenos and their salts, in particular their salts of alkali metals, such as sodium salts (for example, C 1-6 alkyl parabens such as parabens of methyl, ethyl, propyl, butyl and similar parabens), chlorohexidine and the like, iodopropylbutylcarbamate, also called butyl-3-iodo-2-propynyl carbamate. Other preservatives are formaldehyde or formaldehyde releasers, for example, DMDM hydantoin, benzyl alcohol, methylchloroisothiazolinone, methylisothiazolinone, sodium benzoate, chlorohexidine, digluconate, methyldibromo glutanitrile, 5-Bromo-5-nitro-1,3-dioxane, benzoic acid, dehydroacetic acid, diazolidinylurea, polyamopropylbiguanide, potassium sorbate, quaternium-15, sorbic acid, triclosan and Similar. As used herein, the term "preservative" It also includes mixtures of preservatives.
La relación ponderal de ácido anísico a la cantidad total de monoglicéridos de ácido graso C_{6-14}, esto es, ácido anísico:monoglicéridos de ácido graso C_{6-14}, puede estar en el intervalo de 20:1 a 1:1000, en particular de 15:1 a 1:100, más en particular de 10:1 a 1:30, aún más en particular de 1:1 a 1:20, o de 1:1 a 1:10. Preferiblemente, la relación mencionada está en el intervalo de 1:2 a 1.8, por ejemplo, es de aproximadamente 1:5. Las relaciones ponderales expresadas aquí son en relación al ácido anísico y es necesario recalcularlas de la forma procedente cuando se usan en forma de sal o de éster.The weight ratio of anisic acid to total amount of fatty acid monoglycerides C_ {6-14}, that is, anisic acid: monoglycerides of C 6-14 fatty acid, may be in the range from 20: 1 to 1: 1000, in particular from 15: 1 to 1: 100, more in particular from 10: 1 to 1:30, even more particularly from 1: 1 to 1:20, or from 1: 1 to 1:10. Preferably, the aforementioned relationship is in the range from 1: 2 to 1.8, for example, is about 1: 5. The weight ratios expressed here are in relation to acid anisic and it is necessary to recalculate them in the appropriate way when they are used in the form of salt or ester.
El término actividad conservante eficaz significa que su actividad es tal que la composición o formulación está protegida durante un período sostenido de tiempo, en particular durante la denominada "vida hasta caducidad" del producto. La "vida hasta caducidad" de un producto se determina de acuerdo con procedimientos generalmente conocidos en la técnica.The term effective preservative activity means that its activity is such that the composition or formulation is protected for a sustained period of time, in particular during the so-called "life until expiration" of the product. The "life until expiration" of a product is determined according with procedures generally known in the art.
Las formulaciones tópicas de la invención comprenden tanto formulaciones dermatológicas (o formulaciones farmacéuticas tópicas) como formulaciones cosméticas. Tales formulaciones tópicas pueden contener además otros ingredientes o aditivos usados en formulaciones dermatológicas o cosméticas, incluidos otros ingredientes activos.Topical formulations of the invention comprise both dermatological formulations (or formulations topical pharmaceuticals) as cosmetic formulations. Such topical formulations may also contain other ingredients or additives used in dermatological or cosmetic formulations, including other active ingredients.
Las formulaciones de acuerdo con la presente invención se formulan en formas que son útiles en productos cosméticos. Son de particular interés las formulaciones que están en forma de emulsión. Las formulaciones son en particular para aplicación en pieles sensibles. Las realizaciones de particular interés son formulaciones para uso en productos autobronceadores. Éstos comprenden cualquiera de las formulaciones descritas en esta memoria que adicionalmente comprenden una cantidad eficaz de un agente autobronceador, en particular DHA. En la mayoría de los casos, las formulaciones autobronceadoras se usan sobre pieles sensibles porque los usuarios que tienen este tipo de piel desean tener un color moreno de la piel, pero no quieren o no pueden correr el riesgo de dañar la piel por exposición a la radiación solar.The formulations in accordance with this invention are formulated in forms that are useful in products Cosmetics Of particular interest are the formulations that are in the form of emulsion. The formulations are in particular for application on sensitive skin. The realizations of particular Interest are formulations for use in self tanning products. These comprise any of the formulations described in this memory that additionally comprise an effective amount of a self tanning agent, particularly DHA. In most of the cases, self-tanning formulations are used on skins sensitive because users who have this type of skin want have a brown skin color, but they don't want or can't run the risk of damaging the skin by exposure to solar radiation.
Las formulaciones autobronceadoras contienen una cantidad eficaz de ingrediente activo autobronceador, en particular de DHA. El ingrediente activo autobronceador puede estar presente en concentraciones que están en el intervalo de 1-10% en peso, preferiblemente de 2-8% en peso, por ejemplo, de aproximadamente 5% en peso.Self-tanning formulations contain a effective amount of self-tanning active ingredient, in particular of DHA. The self-tanning active ingredient may be present in concentrations that are in the range of 1-10% by weight, preferably 2-8% by weight, per example, about 5% by weight.
Las formulaciones tópicas de acuerdo con la presente invención pueden contener adicionalmente otros ingredientes o aditivos tales como disolventes, tensioactivos, emulsivos, factores consistentes, acondicionadores, emolientes, ingredientes para el cuidado de la piel, hidratantes, espesativos, lubricantes, cargas, antioxidantes, conservantes, ingredientes activos, en particular ingredientes dermatológicamente activos, agentes fragantes y similares.Topical formulations according to the The present invention may additionally contain other ingredients. or additives such as solvents, surfactants, emulsifiers, consistent factors, conditioners, emollients, ingredients for skin care, moisturizers, thickeners, lubricants, fillers, antioxidants, preservatives, active ingredients, in particular dermatologically active ingredients, agents Fragrant and similar.
Las formulaciones pueden contener tensioactivos, que pueden ser catiónicos, no iónicos o anfóteros. El grupo de tensioactivos adecuados comprende:The formulations may contain surfactants, which can be cationic, nonionic or amphoteric. The group of Suitable surfactants include:
- --
- alquilsulfatos, por ejemplo, laurilsulfato sódico, laurilsulfato amónico, cetearilsulfato sódico,alkyl sulfates, for example, sodium lauryl sulfate, ammonium lauryl sulfate, cetearylsulfate sodium,
- --
- alquilsulfoacetatos, por ejemplo, laurilsulfoacetato sódico, alquil éter sulfatos, por ejemplo, lauril éter sulfato sódico, tridecil éter sulfato sódico, polietilenglicol oleil éter sulfato sódico, lauril éter sulfato amónico,alkylsulfoacetates, for example, sodium lauryl sulfoacetate, alkyl ether sulfates, for example, lauryl sodium ether sulfate, tridecyl ether sodium sulfate, polyethylene glycol Sodium Oleyl Ether Sulfate, Ammonium Lauryl Ether Sulfate,
- --
- alquil éter sulfosuccinatos, por ejemplo, lauril éter sulfosuccinato disódico,rent ether sulfosuccinates, for example, lauryl ether sulfosuccinate disodium
- --
- alquilglicósidos, por ejemplo, decilglucósido, laurilglucósido,alkyl glycosides, for example, decylglycoside, laurylglucoside,
- --
- alquilisetionatos,alkylisethionates,
- --
- teensioactivos anfóteros, por ejemplo, cocoamidopropilbetaína, cocoanfoacetato sódico, lauroanfoacetato sódico, lauroanfodiacetato disódico, cocoanfodiacetato disódico, lauroanfopropionato sódico, lauroanfodipropionato disódico, sales potásicas o amónicas de los mencionados anfóteros, capril/capramidopropil betaína, undecilenamidopropil betaína, lauramidopropilbetaína yamphoteric teens, for example, cocoamidopropyl betaine, sodium cocoamphoacetate, lauroamphoacetate sodium, disodium lauroampodiacetate, disodium cocoampodiacetate, sodium lauroanphopropionate, disodium lauroanphodipropionate, salts potassium or ammonium of the aforementioned amphoteric, capril / capramidopropyl betaine, undecylenamidopropyl betaine, lauramidopropyl betaine and
- --
- alcohol graso poliglicol éteres.polyglycol fatty alcohol ethers
Los emulsivos adecuados son, por ejemplo, aniónicos como sales de ácidos grasos, por ejemplo estearato sódico o palmitato sódico, jabones orgánicos, por ejemplo, mono-, di- o trietanolaminooleato, compuestos sulfatados o sulfonados, por ejemplo, laurilsulfato sódico o cetilsulfonato sódico, saponinas, lamepones, catiónicos tales como sales de amonio cuaternario, no iónicos tales como alcoholes grasos, ésteres de ácido graso con ácidos grasos saturados o insaturados, polioxietilenésteres o polioxietilenéteres de ácidos grasos, polímeros de óxido de etileno y óxido de propileno o propilenglicol, anfóteros tales como fosfátidos, proteínas como gelatina, caseinalquilamidobetaínas, alquilbetainas y anfoglicinatos, alquilfosfatos, alquilpolioxietilenfosfatos o los correspondientes ácidos, derivados de silicona, por ejemplo, alquildimeticonapoliol.Suitable emulsifiers are, for example, anionic as fatty acid salts, for example sodium stearate or sodium palmitate, organic soaps, for example, mono-, di- or triethanolaminooleate, sulfated or sulphonated compounds, by example, sodium lauryl sulfate or sodium cetyl sulphonate, saponins, lamepones, cationic such as quaternary ammonium salts, not ionics such as fatty alcohols, fatty acid esters with saturated or unsaturated fatty acids, polyoxyethylene esters or polyoxyethylene fatty acid ethers, ethylene oxide polymers and propylene oxide or propylene glycol, amphoteric such as phosphatides, proteins such as gelatin, caseinalkylamidobetains, alkyl betaines and amphoglycinates, alkyl phosphates, alkylpolyoxyethylene phosphates or the corresponding acids, silicone derivatives, for example, alkyldimethiconapoliol.
Los factores de consistencia adecuados son, por ejemplo, alcoholes grasos o sus mezclas con ésteres de ácido graso, por ejemplo, alcohol lanolínico etoxilado, estearatos de aluminio, carbómeros, alcohol cetílico, oleato de glicerilo, estearato de glicerilo, estearato de glicerilo (y) estearato de PEG 100, estearato magnésico, sulfato magnésico, ácido oleico, ácido esteárico, alcohol estearílico, miristato de miristilo, palmitato de isopropilo, cera de abeja y sus equivalentes sintéticos, carbómeros, etc. Los acondicionadores adecuados son, por ejemplo, lactato alquilamidoamónico, cloruro de cetrimonio y metosulfato de diestearoiletilhidroxietilamonio y alcohol cetearílico, cetildimeticona, rinooleato de cetilo, dimeticona, laureth-23, laureth-4, polideceno, palmitato de retinilo, hidrolizados de proteína cuaternizada, celulosa cuaternizada y derivados de almidón, copolímeros cuaternizados de ácido acrílico o metacrílico o sus sales, derivados de silicona cuaternizados.The appropriate consistency factors are, by for example, fatty alcohols or mixtures thereof with fatty acid esters, for example, ethoxylated lanolinic alcohol, aluminum stearates, carbomers, cetyl alcohol, glyceryl oleate, stearate Glyceryl, glyceryl stearate (and) PEG 100 stearate, magnesium stearate, magnesium sulfate, oleic acid, acid stearic, stearyl alcohol, myristyl myristate, palmitate isopropyl, beeswax and its synthetic equivalents, carbomers, etc. Suitable conditioners are, for example, alkylamido ammonium lactate, cetrimonium chloride and methosulfate distearoylethylhydroxyethylammonium and cetearyl alcohol, cetyl dimethicone, cetyl rhinoleate, dimethicone, laureth-23, laureth-4, polydecene, retinyl palmitate, quaternized protein hydrolysates, quaternized cellulose and starch derivatives, copolymers quaternized acrylic or methacrylic acid or its salts, derivatives Quaternized silicone.
Son emolientes adecuados, por ejemplo, isononanoato de cetearilo, octanoato de cetearilo, oleato de decilo, estearato de isooctilo, caprilato/caprato de coco, hidroxiestearato de etilhexilo, isononanoato de etilhexilo, isoiestearato de isopropilo, miristato de isopropilo, oleato de oleílo, laurato de hexilo, parafina líquida, PEG-75 lanolina, cocoato de PEG-7 glicerilo, vaselina, ozoquerita, ciclometicona, dimeticona, dimeticona copoliol, dicaprilil éter, butirospermum parkii, jojoba, canola, cera carnauba, copernicia cerifera, onagra, palma africana, almendro, escualeno, maíz, soja de glicina, girasol, lanolina, aceite de ricino, hidrogenado, aceite de coco hidrogenado, poliisobuteno hidrogenado, cocoato de sacarosa, estearoxidimeticona, alcohol lanolínico, isohexadecano.They are suitable emollients, for example, cetearyl isononanoate, cetearyl octanoate, decyl oleate, isooctyl stearate, caprylate / coconut caprate, hydroxystearate of ethylhexyl, ethylhexyl isononanoate, isoistearate isopropyl, isopropyl myristate, oleyl oleate, laurate hexyl, liquid paraffin, PEG-75 lanolin, cocoate of PEG-7 glyceryl, petrolatum, ozoquerite, cyclomethicone, dimethicone, dimethicone copolyol, dicaprilyl ether, butirospermum parkii, jojoba, canola, carnauba wax, copernicia cerifera, evening primrose, African palm, almond, squalene, corn, soy Wisteria, sunflower, lanolin, castor oil, hydrogenated oil of hydrogenated coconut, hydrogenated polyisobutene, cocoa sucrose, stearoxidimeticone, lanolinic alcohol, isohexadecane
Son hidratantes adecuados, por ejemplo, butilenglicol, alcohol cetílico, dimeticona, tartrato de miristilo, glucosa, glycereth-26, glicerina, estearato de glicerilo, proteína de leche hidrolizada, ácido láctico, lactosa y otros azúcares, laureth-8, lecitina, octooxiglicerina, PEG-12, PEG-135, PEG-150, PEG-20, PEG-8, pentilengluiciol, hexilenglicol, fitantriol, polyquaternium-39, PEG-20 metilglucosa éter, propilenglicol, hialuronato sódico, lactato sódico, PCA sódico, sorbitol, succinoglicano, cera de abeja sintética, citrato de tri alquilo C_{14-15}, almidón.They are suitable moisturizers, for example, butylene glycol, cetyl alcohol, dimethicone, myristyl tartrate, glucose, glycereth-26, glycerin, stearate glyceryl, hydrolyzed milk protein, lactic acid, lactose and other sugars, laureth-8, lecithin, octooxiglycerin, PEG-12, PEG-135, PEG-150, PEG-20, PEG-8, pentylene glycol, hexylene glycol, phytantriol, polyquaternium-39, PEG-20 methylglucose ether, propylene glycol, sodium hyaluronate, lactate sodium, sodium PCA, sorbitol, succinoglycan, beeswax synthetic, C 14-15 tri alkyl citrate, starch.
Son espesativos adecuados, por ejemplo, copolímero de acrilatos/metacrilato de steareth-20, carbómero, carboximetilalmidón, cera alba, polímero reticulado de dimeticona/vinildimeticona, alginato de propilenglicol, hidroxietilcelulosa, hidroxipropilmetilcelulosa, sílice, sililato de dimetilo de sílice, goma de xantano, copolímero de butileno hidrogenado/etileno/estireno.They are suitable thickeners, for example, steareth-20 acrylate / methacrylate copolymer, carbomer, carboxymethyl starch, alba wax, crosslinked polymer dimethicone / vinyldimethicone, propylene glycol alginate, hydroxyethylcellulose, hydroxypropylmethylcellulose, silica, silylate dimethyl silica, xanthan gum, butylene copolymer hydrogenated / ethylene / styrene.
Son lubricantes adecuados, por ejemplo, ácido adípico, ácido fumárico y sus sales, triaceteto de glicerina, laurilsulfato sódico o magnésico, estearato magnésico, polietilenglicol sólido, polivinilpirrolidona, ácido bórico, monolaurato o monopalmitato, alcohol miristílico, alcohol cetílico, alcohol cetilestearílico, talco, sales cálcicas o magnésicas de ácidos grasos superiores, mono-, di.- o triglicéridos de ácidos grasos superiores, politetrafluoroetileno.They are suitable lubricants, for example, acid adipic acid, fumaric acid and its salts, glycerin triacetete, sodium or magnesium lauryl sulfate, magnesium stearate, solid polyethylene glycol, polyvinylpyrrolidone, boric acid, monolaurate or monopalmitate, myristyl alcohol, cetyl alcohol, cetyl stearyl alcohol, talc, calcium or magnesium salts of higher fatty acids, mono-, di.- or triglycerides of acids higher fatty, polytetrafluoroethylene.
Los ejemplos de agentes activos para uso en las formulaciones comprenden agentes antiinflamatorios, compuestos antiirritadores, agentes antiprurito, agentes hidratantes, ingredientes para el cuidado de la piel, extractos de plantas, vitaminas, sustancias activas antipicor, antiirritadores, agentes anticaspa, agentes antienvejecimiento o antiarrugas, agentes para estirar la piel tales como dimetilaminoetanol (DMAE) y, en particular, sus formas de sal. Otros ingredientes activos adecuados son, por ejemplo, Medicago officinalis, alantoína, aloe vera, avena, betacaroteno, bisabol, borraja, alcanfor, cloruro de cetilpiridinio, manzanilla común, péptidos de cobre tales como tripéptido-1 de cobre, diclorofenilimidazoldioxolano, etilpantenol, farnesol, ácido ferúlico, genciana amarilla, Ginkgo biloba, soja, Hammamelis virginiana, heliotropina, proteína de trigo hidrolizada, lactosa, linalool, lisina, mango, manitol, mentol, lactato de mentilo, olaflur, arroz, pantenol, aspartato potásico, sorbato potásico, almendro, retinoides tales como retinol, retinal, ácido retinoico, ésteres de retinol tales como palmitato de retinilo, ricino, ácido salicílico, sarcosina, carboximetilbetaglucano sódico, cocoilaminoácidos sódicos, hialuronato sódico, palmitoilprolina sódica, talco, tocoferol, acetato de tocoferilo, tirosina, urea, valina, óxido de zinc, sulfato de zinc y similares.Examples of active agents for use in the formulations include anti-inflammatory agents, anti-irritating compounds, anti-irritation agents, moisturizing agents, skin care ingredients, plant extracts, vitamins, anti-corrosive active substances, anti-irritants, anti-dandruff agents, anti-aging or anti-wrinkle agents. agents for stretching the skin such as dimethylaminoethanol (DMAE) and, in particular, its salt forms. Other suitable active ingredients are, for example, Medicago officinalis , allantoin, aloe vera, oats, beta-carotene, bisabol, borage, camphor, cetylpyridinium chloride, common chamomile, copper peptides such as copper tripeptide-1, dichlorophenylimidazoldioxolane, ethylpanthenol, farnesol , ferulic acid, yellow gentian, Ginkgo biloba , soy, Hammamelis virginiana , heliotropin, hydrolyzed wheat protein, lactose, linalool, lysine, mango, mannitol, menthol, menthol lactate, olaflur, rice, panthenol, potassium aspartate, potassium sorbate, almond, retinoids such as retinol, retinal, retinoic acid, retinol esters such as retinyl palmitate, castor, salicylic acid, sarcosine, sodium carboxymethylbetaglucan, sodium cocoylamino acids, sodium hyaluronate, palmitoylproline sodium, talc, tocopherol, acetate, tocopherol, acetate, tocopherol, acetate, tocopherol, acetate urea, valine, zinc oxide, zinc sulfate and the like.
Las formulaciones de la invención pueden estar basadas en agua o pueden ser emulsiones, ambas de aceite en agua, y agua en aceite, en soluciones acuosas, en emulsiones PIT (temperatura de inversión de fase), en soluciones oleosas, en formulaciones cosméticas que espuman (espumas), y en las llamadas emulsiones múltiples, por ejemplo, en emulsiones triples (tales como emulsiones agua/aceite/agua). Las formulaciones de la invención pueden tener la forma de champúes, geles, líquidos o lociones. Se pueden usar en champúes, acondicionadores del cabello, tintes para el cabello, preparados para el cabello, lociones para después del afeitado, jabones y detergentes para el baño, preparados fragantes, productos para protección solar, productos bronceadores en el interior, preparados para el cuerpo y las manos, productos para la limpieza personal, preparados para el afeitado, tónicos, aprestos y otros coadyuvantes para arreglar el cabello, preparados hidratantes, preparados para el cuidado de la piel y similares.The formulations of the invention may be water based or they can be emulsions, both oil in water, and water in oil, in aqueous solutions, in PIT emulsions (phase inversion temperature), in oily solutions, in cosmetic formulations that foam (foams), and in calls multiple emulsions, for example, in triple emulsions (such as water / oil / water emulsions). The formulations of the invention They can be in the form of shampoos, gels, liquids or lotions. Be can use in shampoos, hair conditioners, dyes for hair, hair preparations, lotions after shaving, soaps and bath detergents, fragrant preparations, sunscreen products, tanning products in the interior, prepared for the body and hands, products for the personal cleaning, shaving preparations, tonics, dressings and other adjuvants to fix the hair, moisturizing preparations, Skin care preparations and the like.
Las formulaciones tópicas de la invención se preparan mezclando individualmente los ingredientes o mezclándolos por grupos. Luego se pueden añadir otros ingredientes. El disolvente se puede añadir después de mezclar, o los componentes se mezclan mientras que están presentes en un disolvente. Se puede preparar primeramente una premezcla de ácido anísico, o una sal o un éster de él y un monoglicérido de ácido graso C_{6-14}, opcionalmente mezclada con un disolvente adecuado, añadiéndose después los otros componentes.Topical formulations of the invention are prepare by mixing the ingredients individually or mixing them By groups. Then you can add other ingredients. Solvent It can be added after mixing, or the components are mixed while they are present in a solvent. Can be prepared first a premix of anisic acid, or a salt or an ester of it and a C 6-14 fatty acid monoglyceride, optionally mixed with a suitable solvent, adding Then the other components.
Las formulaciones de la presente invención son útiles para su aplicación sobre tipos de piel sensibles, en especial en personas con un tipo de piel atópico.The formulations of the present invention are useful for application on sensitive skin types, in Special in people with an atopic skin type.
En otro aspecto, esta invención concierne a los efectos sinérgicos entre dos agentes, ácido anísico o una de sus sales o uno de sus ésteres, por una parte, un monoglicérido de ácido graso C_{6-14} por otra, en términos de actividad antimicrobiológica, así como de espectro antimicrobiológico. El uso de ácido anísico o una de sus sales o uno de sus ésteres, y un monoglicérido de ácido graso C_{6-14} en formulaciones cosméticas da por resultado una amplia protección antimicrobiana y una buena tolerancia por la piel. La protección antimicrobiana es también contra bacterias tales como hongos, en particular frente a especies tales como Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Candida albicans, Aspergillus Níger.In another aspect, this invention concerns the synergistic effects between two agents, anisic acid or one of its salts or one of its esters, on the one hand, a C 6-14 fatty acid monoglyceride on the other, in terms of activity antimicrobiological, as well as antimicrobiological spectrum. The use of anisic acid or one of its salts or one of its esters, and a C 6-14 fatty acid monoglyceride in cosmetic formulations results in extensive antimicrobial protection and good skin tolerance. Antimicrobial protection is also against bacteria such as fungi, particularly against species such as Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Candida albicans, Aspergillus Niger .
Las combinaciones de ácido anísico o una de sus sales o uno de sus ésteres, y caprilato de glicerilo se pueden usar como un sistema conservante en formulaciones para uso sobre la piel, tales como formulaciones para el cuidado personal o cosméticas. Las mencionadas composiciones permiten reducir la cantidad de conservantes tradicionales en tales formulaciones, o incluso eliminar completamente tales conservantes y, además son útiles en formulaciones para aplicación en tipos de piel sensibles. Las mencionadas combinaciones se pueden usar en particular en formulaciones que contienen ingredientes lábiles tales como ingredientes activos que son descompuestos por ingredientes conservantes tradicionales. Un ejemplo de tales ingredientes activos es el DHA. Por ello, las combinaciones de la presente invención pueden tener uso en formulaciones, más en particular emulsiones, para uso en aplicaciones autobronceadoras.The combinations of anisic acid or one of its salts or one of its esters, and glyceryl caprylate can be used as a preservative system in formulations for use on the skin, such as personal care or cosmetic formulations. The mentioned compositions allow to reduce the amount of traditional preservatives in such formulations, or even completely eliminate such preservatives and are also useful in Formulations for application on sensitive skin types. The mentioned combinations can be used in particular in formulations containing labile ingredients such as active ingredients that are broken down by ingredients Traditional preservatives An example of such active ingredients It is the DHA. Therefore, the combinations of the present invention may have use in formulations, more particularly emulsions, for use in self tanning applications.
Otro ejemplo de ingredientes activos son los filtros solares y, por tanto, las formulaciones de la invención pueden tener la forma de formulaciones de filtros solares.Another example of active ingredients are the sunscreens and, therefore, the formulations of the invention They can be in the form of sunscreen formulations.
Las formulaciones de la invención son particularmente atractivas porque los agentes contenidos en ellas tienen una buena acción contra Staphylococcus aureus y hongos tales como Apergillus níger. Las formulaciones de la invención, por ello, son muy útiles en los casos en los que es necesario disminuir la cantidad de parabenos porque típicamente los parabenos se usan para la protección frente a hongos. Este es el caso en particular con los tipos de piel atópicos que tienen tendencia a desarrollar esta clase de bacterias y que toleran poco los parabenos.The formulations of the invention are particularly attractive because the agents contained therein have a good action against Staphylococcus aureus and fungi such as Apergillus niger . The formulations of the invention, therefore, are very useful in cases where it is necessary to decrease the amount of parabens because parabens are typically used for fungal protection. This is the case in particular with atopic skin types that have a tendency to develop this kind of bacteria and that tolerate parabens little.
Además, la combinación de los dos agentes mencionados antes en esta memoria puede tener aplicaciones farmacéuticas y, a este fin, se puede formular en formulaciones apropiadas para aplicaciones farmacéuticas tópicas. Por ello, en otro aspecto más, la invención proporciona composiciones farmacéuticas tópicas que comprenden una composición como se ha definido en esta memoria. La composición está presente en una cantidad para conservar eficazmente las mencionadas composiciones farmacéuticas.In addition, the combination of the two agents mentioned above in this memory may have applications pharmaceuticals and, to this end, can be formulated in formulations appropriate for topical pharmaceutical applications. Therefore, in yet another aspect, the invention provides compositions topical pharmaceuticals comprising a composition as has been defined in this memory. The composition is present in a amount to effectively preserve said compositions Pharmaceuticals
La invención se ilustra más con el ejemplo siguiente.The invention is further illustrated by the example. next.
EjemploExample
Se prepararon una primera mezcla que contenía los componentes lipófilos y una segunda mezcla que contenía el agua y los ingredientes compatibles con el agua. Posteriormente se añadió la fase oleosa a la fase acuosa con una agitación intensa para formar una emulsión.A first mixture containing lipophilic components and a second mixture containing water and water compatible ingredients. It was subsequently added the oil phase to the aqueous phase with intense agitation to form an emulsion
Claims (11)
- (a)(to)
- de 0,01 a 2% en peso de ácido anísico, o una de sus sales o uno de sus ésteres de alquilo C_{1-4}, yfrom 0.01 to 2% by weight of anisic acid, or one of its salts or one of its C 1-4 alkyl esters, and
- (b)(b)
- de 0,1 a 10% en peso de un monoglicérido de ácido graso C_{6-14}.from 0.1 to 10% by weight of a fatty acid monoglyceride C_ {6-14}.
- (a)(to)
- de 0,01 a 2% en peso de ácido p-anísico, o una de sus sales o uno de sus ésteres, yfrom 0.01 to 2% by weight of p-anisic acid, or one of its salts or one of its esters, and
- (b)(b)
- de 0,1 a 10% en peso de caprilato de glicerilo,from 0.1 to 10% by weight of glyceryl caprylate,
- (c)(C)
- menos de 1% en peso de agente conservante.less than 1% by weight of agent preservative
- (a)(to)
- de 0,01 a 2% en peso de ácido p-anísico, o una de sus sales o uno de sus ésteres, yfrom 0.01 to 2% by weight of p-anisic acid, or one of its salts or one of its esters, and
- (b)(b)
- de 0,1 a 10% de caprilato de glicerilo,from 0.1 to 10% glyceryl caprylate,
- (c)(C)
- menos de 0,4% en peso de parabenos, o menos de 100 ppm de yodopropinilbutilcarbamato, o menos de 0,5% de fenoxietanol.less than 0.4% by weight of parabens, or less than 100 ppm of iodopropylbutylcarbamate, or less than 0.5% of phenoxyethanol
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03293147A EP1541124B1 (en) | 2003-12-12 | 2003-12-12 | Compositions with anisic acid and glycerides |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2320643T3 true ES2320643T3 (en) | 2009-05-27 |
Family
ID=34486465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03293147T Expired - Lifetime ES2320643T3 (en) | 2003-12-12 | 2003-12-12 | COMPOSITIONS WITH ANISIC ACID AND GLYCERIDES. |
Country Status (7)
Country | Link |
---|---|
US (1) | US7262217B2 (en) |
EP (1) | EP1541124B1 (en) |
AT (1) | ATE422350T1 (en) |
CA (1) | CA2489932C (en) |
DE (1) | DE60326150D1 (en) |
DK (1) | DK1541124T3 (en) |
ES (1) | ES2320643T3 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE367144T1 (en) * | 2005-04-08 | 2007-08-15 | Straetmans Gmbh Dr | CONCENTRATED AQUEOUS SOLUTIONS OF P-METHOXYBENZOIC ACID FOR USE IN COSMETIC AND DERMATOLOGICAL FORMULATIONS |
DE102005023637A1 (en) * | 2005-05-19 | 2006-11-23 | Beiersdorf Ag | Active substance combination, useful for skin moisturizing and in the cosmetic preparation, comprises dihydroxyacetone and glucosylglyceride |
AU2006265816B2 (en) * | 2005-07-01 | 2012-05-03 | Playtex Products, Inc. | Sunless tanning substrate |
US7378084B2 (en) | 2005-07-01 | 2008-05-27 | Playtex Products, Inc. | Sunless tanning composition and method of sunless tanning |
EP1810659A1 (en) * | 2005-11-28 | 2007-07-25 | Johnson & Johnson Consumer France SAS | Self-tanning compositions |
KR100722673B1 (en) | 2005-12-27 | 2007-05-29 | 주식회사 코리아나화장품 | Cosmetic composition comprising glyceryl caprylate and the extract from sophora flavescens as preservatives |
KR100722674B1 (en) | 2005-12-27 | 2007-05-29 | 주식회사 코리아나화장품 | Cosmetic composition comprising glyceryl caprylate and the extract from sasa borealis as preservatives |
US20070183994A1 (en) * | 2006-02-03 | 2007-08-09 | Toma's, L.L.C. | Self-tanning product having slimming, firming and toning properties associated therewith |
FR2909552B1 (en) * | 2006-12-12 | 2009-11-20 | Oreal | COSMETIC USE OF ANISIC ACID TO PROMOTE DESQUACATION |
ITTO20070857A1 (en) * | 2007-11-28 | 2009-05-29 | Cristina Capelli | CONSERVATIVE COMPOSITION, METHOD FOR ITS PREPARATION, ITS USE AND ITS FORMULATION |
US8367079B2 (en) | 2008-01-25 | 2013-02-05 | Rhodia Operations | Liquid preservative compositions |
FR2940053B1 (en) * | 2008-12-18 | 2011-01-21 | Oreal | USE OF THE ANISIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES AS ANTIOXIDANT AGENT |
WO2012045081A2 (en) * | 2010-10-01 | 2012-04-05 | Mary Kay Inc. | Skin moisturizer and age fighting formula |
DE102011077774A1 (en) * | 2011-06-17 | 2012-12-20 | Beiersdorf Ag | Natural cosmetics compliant preparations |
US20130142740A1 (en) * | 2011-12-02 | 2013-06-06 | Loreal S.A. | Sunscreen compositions containing a novel preservative system |
US9034833B1 (en) | 2013-12-20 | 2015-05-19 | L'oreal | Anti-aging composition containing high levels of a jasmonic acid derivative |
US9539198B2 (en) | 2013-12-20 | 2017-01-10 | L'oreal | Photoprotection composition containing high levels of water-soluble UV filters |
US9545373B2 (en) | 2013-12-20 | 2017-01-17 | L'oreal | Translucent cosmetic composition in the form of a water-in-oil emulsion |
US9237998B2 (en) | 2013-12-20 | 2016-01-19 | L'oreal | Carrier system for water-soluble active ingredients |
US9943477B2 (en) | 2013-12-20 | 2018-04-17 | L'oreal | Emulsion compositions containing a novel preservative system |
WO2016126059A1 (en) * | 2015-02-04 | 2016-08-11 | 임호 | Antibacterial composition and wet tissue comprising antibacterial composition |
US11013681B2 (en) * | 2015-07-15 | 2021-05-25 | Bakel Srl | Cosmetic composition |
EP3709955A1 (en) * | 2017-11-16 | 2020-09-23 | DSM IP Assets B.V. | Topical compositions |
EP4061310A1 (en) | 2019-11-20 | 2022-09-28 | Beiersdorf Aktiengesellschaft | Cosmetic preparation containing anisic acid and levulinic acid, having selective antimicriobial effect |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB297074A (en) * | 1927-06-14 | 1928-09-14 | Ig Farbenindustrie Ag | Process for conserving foods, provisions, technical and pharmaceutical preparations and like substances, and for the manufacture of disinfecting preparations |
JPS4819940B1 (en) * | 1969-06-09 | 1973-06-18 | ||
US3879542A (en) * | 1972-10-16 | 1975-04-22 | Upjohn Co | Anti-arthropodal formulation and method |
JPH0742219B2 (en) * | 1984-07-26 | 1995-05-10 | ライオン株式会社 | Oral composition |
US5609587A (en) * | 1995-08-03 | 1997-03-11 | The Procter & Gamble Company | Diaper having a lotioned topsheet comprising a liquid polyol polyester emollient and an immobilizing agent |
US5607760A (en) * | 1995-08-03 | 1997-03-04 | The Procter & Gamble Company | Disposable absorbent article having a lotioned topsheet containing an emollient and a polyol polyester immobilizing agent |
EP0884045A1 (en) * | 1997-06-06 | 1998-12-16 | Pfizer Products Inc. | Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery |
KR100928878B1 (en) * | 1998-03-19 | 2009-11-30 | 버텍스 파마슈티칼스 인코포레이티드 | Inhibitors of caspases |
FR2834459B1 (en) * | 2002-01-07 | 2006-08-04 | Oreal | MICROBICIDE AGENT AND COSMETIC TREATMENT COMPOSITION CONTAINING THE SAME |
-
2003
- 2003-12-12 ES ES03293147T patent/ES2320643T3/en not_active Expired - Lifetime
- 2003-12-12 DK DK03293147T patent/DK1541124T3/en active
- 2003-12-12 EP EP03293147A patent/EP1541124B1/en not_active Expired - Lifetime
- 2003-12-12 AT AT03293147T patent/ATE422350T1/en active
- 2003-12-12 DE DE60326150T patent/DE60326150D1/en not_active Expired - Lifetime
-
2004
- 2004-12-08 CA CA2489932A patent/CA2489932C/en not_active Expired - Fee Related
- 2004-12-13 US US11/010,485 patent/US7262217B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60326150D1 (en) | 2009-03-26 |
US7262217B2 (en) | 2007-08-28 |
EP1541124B1 (en) | 2009-02-11 |
ATE422350T1 (en) | 2009-02-15 |
EP1541124A1 (en) | 2005-06-15 |
US20050245608A1 (en) | 2005-11-03 |
CA2489932C (en) | 2011-11-08 |
CA2489932A1 (en) | 2005-06-12 |
DK1541124T3 (en) | 2009-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2320643T3 (en) | COMPOSITIONS WITH ANISIC ACID AND GLYCERIDES. | |
EP1206933B1 (en) | Compositions comprising caprylyl glycol and iodopropynyl butylcarbamate | |
ES2324979T3 (en) | NEW CONSERVATIVE SYSTEMS AND THEIR USE IN COSMETIC PREPARATIONS. | |
ES2693347T3 (en) | BPO wash emulsion composition | |
ES2689715T3 (en) | Compositions for skin treatment and methods | |
US20090137534A1 (en) | Skin treatment compositions and methods | |
ES2252383T3 (en) | AGENTS TO PONTENTIATE PRESERVANTS IN SOLAR FILTER FORMULATIONS. | |
US6475991B2 (en) | Use of α-alkylglucosides and α-alkylglucoside esters as anti-microbial an agents | |
EP3061501A1 (en) | Composition for the treatment of acne | |
JP6755796B2 (en) | Multiple emulsion stabilized as a skin protection product | |
US20240091171A1 (en) | Dermatological compositions and uses thereof | |
CA2855045A1 (en) | Topical dapsone for the treatment of acne | |
KR101381903B1 (en) | Antibacterial or preservative composition containing 3-butoxy-1,2-propanediol | |
US20140005131A1 (en) | Active ingredient combinations of glucosyl glycerides and one or more preservatives | |
JP2003026528A (en) | Bleaching cosmetic | |
JP2005232125A (en) | Antiseptic sterilizer, and cosmetic, medicine and food each compounded with the antiseptic sterilizer | |
CA3196181A1 (en) | Topical sanitising composition comprising minimal amounts of an anitmicrobial lipid | |
JP2024083776A (en) | Composition | |
JP2024083777A (en) | Composition | |
WO2011001165A2 (en) | Formulations | |
JP2022503726A (en) | Topical composition |